Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells

Cytokine and Growth Factor Reviews

Volumn 25, Issue 2, 2014, Pages 227-233

  Upadhyay, Vaibhav ^a   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Host defense; Innate lymphoid cells; Lymphotoxin; Metabolic syndrome; Microbiota

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERLEUKIN 22; INTERLEUKIN 23; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LYMPHOTOXIN BETA; RELA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA;

CELL FUNCTION; CELL MATURATION; DISEASE ASSOCIATION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INNATE LYMPHOID CELL; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOID CELL; LYMPHOID ORGAN; METABOLIC SYNDROME X; MICROFLORA; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; CITROBACTER RODENTIUM; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MOUSE; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CITROBACTER RODENTIUM; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-23; INTERLEUKINS; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; METABOLIC SYNDROME X; MICE; MICROBIOTA; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA;

EID: 84899051813     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.12.007     Document Type: Short Survey

References (92)

1. Kelker H.C., Oppenheim J.D., Stone-Wolff D., Henriksen-DeStefano D., Aggarwal B.B., Stevenson H.C., et al. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. International Journal of Cancer 1985, 36:69-73.
2. Ruddle N.H. Tumor necrosis factor (TNF-a) and lymphotoxin. Current Opinion in Immunology 1992, 4:327-332.
3. Pennica D., Nedwin G.E., Hayflick J.S., Seeburg P.H., Derynck R., Palladino M.A., et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984, 312:724-729.
4. Eck M.J., Ultsch M., Rinderknecht E., de Vos A.M., Sprang S.R. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. Journal of Biological Chemistry 1992, 267:2119-2122.
5. Gommerman J.L., Browning J.L. Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease. Nature Reviews Immunology 2003, 3:642-655.
6. Crowe P.D., VanArsdale T.L., Walter B.N., Ware C.F., Hession C., Ehrenfels B., et al. A lymphotoxin-beta-specific receptor. Science 1994, 264:707-710.
7. Fütterer A., Mink K., Luz A., Kosco-Vilbois M.H., Pfeffer K. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998, 9:59-70.
8. Browning J.L., Ngam-ek A., Lawton P., DeMarinis J., Tizard R., Chow E.P., et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72:847-856.
9. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
10. Fu Y.-X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annual Review of Immunology 1999, 17:399-433.
11. Ware C.F., VanArsdale T.L., Crowe P.D., Browning J.L. The ligands and receptors of the lymphotoxin system. Current Topics in Microbiology and Immunology 1995, 198:175-218.
12. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κb pathways. Immunity 2002, 17:525-535.
13. Schneider K., Potter K.G., Ware C.F. Lymphotoxin and LIGHT signaling pathways and target genes. Immunological Reviews 2004, 202:49-66.
14. Ohshima Y., Yang L.P., Avice M.N., Kurimoto M., Nakajima T., Sergerie M., et al. Naive Human CD4+ T Cells Are a Major Source of Lymphotoxin α. The Journal of Immunology 1999, 162:3790-3794.
15. Sacca R., Cuff C.A., Lesslauer W., Ruddle N.H. Differential activities of secreted lymphotoxin-α3 and membrane lymphotoxin-α1β2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. The Journal of Immunology 1998, 160:485-491.
16. Steffen M., Ottmann O.G., Moore M.A. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. Journal of Immunology 1988, 140:2621-2624.
17. Tumanov A.V., Koroleva E.P., Guo X., Wang Y., Kruglov A., Nedospasov S., et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host and Microbe 2011, 10:44-53.
18. Yoshida H., Naito A., Inoue J.-I., Satoh M., Santee-Cooper S.M., Ware C.F., et al. Different cytokines induce surface lymphotoxin-αβ on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002, 17:823-833.
19. Browning J.L., French L.E. Visualization of lymphotoxin-β and lymphotoxin-β receptor expression in mouse embryos. Journal of Immunology 2002, 168:5079-5087.
20. Murphy M., Walter B.N., Pike-Nobile L., Fanger N.A., Guyre P.M., Browning J.L., et al. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death & Differentiation 1998, 5:497-505.
21. Wang Y., Koroleva E.P., Kruglov A.A., Kuprash D.V., Nedospasov S.A., Fu Y.-X., et al. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 2010, 32:403-413.
22. Lo J.C., Wang Y., Tumanov A.V., Bamji M., Yao Z., Reardon C.A., et al. Lymphotoxin β receptor-dependent control of lipid homeostasis. Science 2007, 316:285-288.
23. Girard J.-P., Moussion C., Förster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nature Reviews Immunology 2012, 12:762-773.
24. Moussion C., Girard J.-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011, 479:542-546.
25. Upadhyay V., Fu Y.-X. Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nature Reviews Immunology 2013, 13:270-279.
26. Zhai Y., Guo R., Hsu T.L., Yu G.L., Ni J., Kwon B.S., et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. Journal of Clinical Investigation 1998, 102:1142-1151.
27. Kabashima K., Banks T.A., Ansel K.M., Lu T.T., Ware C.F., Cyster J.G. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
28. Phan T.G., Green J.A., Gray E.E., Xu Y., Cyster J.G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nature Immunology 2009, 10:786-793.
29. Shui J.-W., Larange A., Kim G., Vela J.L., Zahner S., Cheroutre H., et al. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 2012, 488:222-225.
30. Murphy K.M., Nelson C.A., Šedý J.R. Balancing co-stimulation and inhibition with BTLA and HVEM. Nature Reviews Immunology 2006, 6:671-681.
31. Granger S.W., Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine & Growth Factor Reviews 2003, 14:289-296.
32. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., Luz A., Turetskaya R.L., Tarakhovsky A., et al. Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proceedings of the National Academy of Science USA 1997, 94:9302-9307.
33. Cupedo T., Jansen W., Kraal G., Mebius R.E. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 2004, 21:655-667.
34. Eberl G., Marmon S., Sunshine M.-J., Rennert P.D., Choi Y., Littman D.R. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nature Immunology 2003, 5:64-73.
35. van de Pavert S.A., Mebius R.E. New insights into the development of lymphoid tissues. Nature Reviews Immunology 2010, 10:664-674.
36. van de Pavert S.A., Olivier B.J., Goverse G., Vondenhoff M.F., Greuter M., Beke P., et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nature Immunology 2009, 10:1193-1199.
37. Eberl G., Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunology 2009, 2:478-485.
38. Lorenz R.G., Chaplin D.D., McDonald K.G., McDonough J.S., Newberry R.D. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin β receptor, and TNF receptor I function. Journal of Immunology 2003, 170:5475-5482.
39. Golovkina T.V., Shlomchik M., Hannum L., Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science 1999, 286:1965-1968.
40. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 2009, 9:313-323.
41. Hapfelmeier S., Lawson M.A.E., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
42. Tsuji M., Suzuki K., Kitamura H., Maruya M., Kinoshita K., Ivanov I.I., et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008, 29:261-271.
43. Lochner M., Ohnmacht C., Presley L., Bruhns P., Si-Tahar M., Sawa S., et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells. Journal of Experimental Medicine 2011, 208:125-134.
44. Furtado G.C., Pacer M.E., Bongers G., Bénézech C., He Z., Chen L., et al. TNFα-dependent development of lymphoid tissue in the absence of RORγt (+) lymphoid tissue inducer cells. Mucosal Immunology 2013.
45. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610.
46. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K.M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2008, 457:722-725.
47. Eberl G., Littman D.R. Thymic origin of intestinal αβ T cells revealed by fate mapping of RORγt+ cells. Science Signaling 2004, 305:248-251.
48. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 2005, 201:233-240.
49. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
50. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. Journal of Experimental Medicine 2009, 206:35-41.
51. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., et al. Lineage relationship analysis of RORγt+ innate lymphoid cells. Science 2010, 330:665-669.
52. Cherrier M., Sawa S., Eberl G. Notch, Id2, and RORγt sequentially orchestrate the fetal development of lymphoid tissue inducer cells. Journal of Experimental Medicine 2012, 209:729-740.
53. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 2010, 33:736-751.
54. Satoh-Takayama N., Lesjean-Pottier S., Sawa S., Vosshenrich C.A.J., Eberl G., Di Santo J.P. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells. European Journal of Immunology 2011, 41:780-786.
55. Tumanov A.V., Grivennikov S.I., Shakhov A.N., Rybtsov S.A., Koroleva E.P., Takeda J., et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunological Reviews 2003, 195:106-116.
56. Ota N., Wong K., Valdez P.A., Zheng Y., Crellin N.K., Diehl L., et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nature Immunology 2011, 12:941-948.
57. Liang S.C., Tan X.-Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 2006, 203:2271-2279.
58. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of Immunology 2000, 164:1814-1819.
59. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Medicine 2008, 14:282-289.
60. Satoh-Takayama N., Vosshenrich C.A.J., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
61. Spahn T.W., Maaser C., Eckmann L., Heidemann J., Lügering A., Newberry R., et al. The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastroenterology 2004, 127:1463-1473.
62. + dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
63. Spits H., Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annual Review of Immunology 2012, 30:647-675.
64. Aujla S.J., Kolls J.K. IL-22: a critical mediator in mucosal host defense. Journal of Molecular Medicine 2009, 87:451-454.
65. - entheseal resident T cells. Nature Medicine 2012, 18:1069-1076.
66. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
67. Qiu J., Guo X., Chen Z.-M.E., He L., Sonnenberg G.F., Artis D., et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 2013, 39:386-399.
68. Upadhyay V., Poroyko V., Kim T.-J., Devkota S., Fu S., Liu D., et al. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nature Immunology 2012, 13:947-953.
69. Wang Y., Beydoun M.A., Liang L., Caballero B., Kumanyika S.K. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008, 16:2323-2330.
70. Wilson P.W.F., D'Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of Internal Medicine 2002, 162:1867-1872.
71. Willett W.C., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer F.E., et al. Weight, weight change, and coronary heart disease in women. JAMA: Journal of the American Medical Association 1995, 273:461-465.
72. Field A.E., Willett W.C., Lissner L., Colditz G.A. Dietary fat and weight gain among women in the Nurses' Health Study[ast]. Obesity 2007, 15:967-976.
73. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA: Journal of the American Medical Association 2002, 287:356-359.
74. Leroy P., Dessolin S., Villageois P., Moon B.C., Friedman J.M., Ailhaud G., et al. Expression of ob gene in adipose cells. Journal of Biological Chemistry 1996, 271:2365-2368.
75. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011, 11:85-97.
76. Norman R.A., Bogardus C., Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. Journal of Clinical Investigation 1995, 96:158-162.
77. Hamid Y.H., Urhammer S.A., Gl mer C., Borch-Johnsen K., Jrgensen T., Hansen T., et al. The common T60N polymorphism of the lymphotoxin-α gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia 2005, 48:445-451.
78. Mahajan A., Tabassum R., Chavali S., Dwivedi O.P., Chauhan G., Tandon N., et al. Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians. Journal of Molecular Medicine 2010, 88:515-522.
79. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., et al. Functional SNPs in the lymphotoxin-[alpha] gene that are associated with susceptibility to myocardial infarction. Nature Genetics 2002, 32:650-654.
80. Yamada A., Ichihara S., Murase Y., Kato T., Izawa H., Nagata K., et al. Lack of association of polymorphisms of the lymphotoxin α gene with myocardial infarction in Japanese. Journal of Molecular Medicine 2004, 82:477-483.
81. Upadhyay V., Fu Y.X. Linking the microbiota and metabolic disease with lymphotoxin. International Immunology 2013, 25:397-403.
82. -/- mice. Journal of Experimental Medicine 2009, 206:233-248.
83. Pamir N., McMillen T.S., Edgel K.A., Kim F., LeBoeuf R.C. Deficiency of lymphotoxin-alpha does not exacerbate high fat diet induced obesity but does enhance inflammation in mice. AJP: Endocrinology and Metabolism 2012, 302:E961-E971.
84. Pamir N., McMillen T.S., Kaiyala K.J., Schwartz M.W., LeBoeuf R.C. Receptors for tumor necrosis factor-play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 2009, 150:4124-4134.
85. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1131.
86. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences 2007, 104:979-984.
87. Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 2008, 3:213-223.
88. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
89. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Science USA 2005, 102:11070-11075.
90. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 2009, 1. 6ra14-4.
91. Hildebrandt M.A., Hoffmann C., Mix S.A.S., Keilbaugh S.A., Hamady M., Chen Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724. e2.
92. Hogan S.P., Seidu L., Blanchard C., Groschwitz K., Mishra A., Karow M.L., et al. Resistin-like molecule β regulates innate colonic function: barrier integrity and inflammation susceptibility. Journal of Allergy and Clinical Immunology 2006, 118:257-268.